Item 5.07. Submission of Matters to a Vote of Security Holders.
On Wednesday, June 1, 2022, Rain Therapeutics Inc. (the "Company") held its 2022
Annual Meeting of Stockholders (the "2022 Annual Meeting") at 10:00 a.m. Pacific
Time. As of the close of business on April 7, 2022, the record date for the 2022
Annual Meeting, there were 18,799,405 shares of the Company's voting common
stock issued and outstanding. At the 2022 Annual Meeting, each of the Company's
director nominees was elected and the other proposal voted on was approved. The
final voting results are set forth below:
Votes Votes Broker
For Withheld Non-Votes
Proposal 1. Election of Class I Directors
? Aaron Davis 8,418,005 1,841,899 3,520,142
? Gorjan Hrustanovic, Ph.D. 9,059,104 1,200,800 3,520,142
Votes Votes Broker
For Against Abstentions Non-Votes
Proposal 2. Ratification of Ernst &
Young LLP as Independent Auditor 13,778,188 709 1,149 0
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses